Skip to content
Search

Latest Stories

NAWP calls on employers to publish gender pay gap reports; PDA backs ethnicity pay gap reporting

The National Association of Women Pharmacists has called on community pharmacy employers to publish their 2019-20 gender pay gap reports immediately.

“Gender equality should continue to be treated as important and that there is no need for good employers to delay publishing their 2019-20 gender pay gap report until the new October enforcement deadline,” the women pharmacists' body said.


The Equality and Human rights Commission’s enforcement action was suspended last year due to the pandemic and now employers have set the October 5 deadline to publish their 2019-20 gender report.

The Pharmacists' Defence Association (PDA) has said that employers should not wait until they risk enforcement before publishing this information and they should publish it as soon as possible, preferably by their usual date.

Naina Chotai, president of NAWP, said: “Singling out equality reporting as something that can be delayed gives the message that equality is not as important as other workplace issues. We disagree. Equality isn’t an optional extra, it should be at the core of how organisations work.

“Efforts to remove inequality from the workplace should always be a priority and employers should not delay publishing their reports along with any plans they have to improve equality”.

While current equality pay gap reporting is limited to gender, the PDA has called for ethnicity pay gap reporting to also become a requirement.

“By measuring and reporting differences in how those with different characteristics are rewarded at work, employers can often identify the structural inequalities that shape reward or influence career progression. Employers can then take action to remove those barriers to equality,” the association has said.

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less